AlphaCentric Advisors’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

AlphaCentric Advisors’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-70,000	Closed	-$860K	–	222
2022 Q4	$860K	Buy	+70,000	New	+$1.67M	0.85%	43

AlphaCentric Advisors's CINC Position: Q1 2023 in Review

AlphaCentric Advisors sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 70,000 shares — an estimated $860K sold.

AlphaCentric Advisors first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $860K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

AlphaCentric Advisors reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
AlphaCentric Advisors sold 70,000 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $860K.
AlphaCentric Advisors first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
AlphaCentric Advisors's CinCor Pharma, Inc. Common Stock position peaked at $860K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on AlphaCentric Advisors's 13F filing for Q1 2023, filed 12 May 2023.